Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Reitz, CA
Bruce A. Reitz, Stanford, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080207496 | ORGANIC COMPOUND - A combination which comprises (a) a staurosporine derivative and (b) an agent effective in preventing, delaying or treating transplant rejection in which the active ingredients (a) and (b) are present in each case in free form or in the form of a pharmaceutically acceptable salt and optionally at least one pharmaceutically acceptable carrier; for simultaneous, separate or sequential use. | 08-28-2008 |
James Reitz, San Francisco, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080262913 | OPTIMIZING ELECTRONIC DISPLAY OF ADVERTISING CONTENT - In one embodiment, a selection process executing in an optimizing engine is invoked as users are presented with web pages that include ad content. The selection process provides an initial population of sets of characteristics that specify an initial generation of layouts of ads for the pages. The characteristics can include anything that affects an ads appearance on the display. For example, ad type, position within a web page, color, size, text font, animation, etc. can be specified. Statistics are obtained as to each ad or page layout's performance or impact on the user, such as revenue obtained from ads in the layout, how many user's click an ad, how long users view an ad, etc. Once a large enough sample of user impacts is obtained a second population of sets of characteristics is created to improve the overall performance of the initial population. In a preferred embodiment, genetic computational procedures are used to create each population and to create new characteristic sets and remove underperforming sets. | 10-23-2008 |
James Allen Reitz, Ventura, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20120116322 | METHOD TO FABRICATE A NEEDLE HAVING A TAPERED PORTION BETWEEN A DISTAL TIP AND A LONGITUDINAL CHANNEL - A novel method to fabricate a needle includes stamping an elongated shape in a flat metal sheet. The elongated shape defines a longitudinal axis and two edges that are substantially parallel to the longitudinal axis. Each of the two edges includes an inward curve with relative alignment to create a relatively narrow neck. A longitudinal channel is formed to give the elongated shape a U-shaped cross-section in a plane normal to the longitudinal axis. The method includes punching through the neck with a punch that slides along a punching axis that intersects the longitudinal axis with an angle in the range 15° to 50°. Alternatively the method includes coining a thinned region that spans the neck and may define a V-shape in a major plane of the flat metal sheet, and separating the elongated shape along the thinned region after coining. | 05-10-2012 |
James Norton Reitz, Oakland, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110072343 | OPTIMIZING ONLINE ADVERTISING LINK AND TEXT CHARACTERISTICS - In one embodiment, a method for displaying advertising content on a display device includes determining at least one color characteristic of the advertising content and the main content in a web page. The method also includes changing a first level of the at least one color characteristic for at least one portion of the advertising content in a first direction, and changing a second level of the at least one color characteristic for at least one portion of the main content in a second direction. | 03-24-2011 |
Richard Reitz, San Clemente, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080311671 | Mass Spectrometry Method for Measuring Vitamin B6 in Body Fluid - Provided are methods of detecting the presence or amount of the active form of vitamin B6, pyridoxal 5′-phosphate, in a body fluid sample using tandem mass spectrometry coupled with liquid chromatography. | 12-18-2008 |
| 20090093009 | MASS SPECTROMETRY METHOD FOR MEASURING THIAMINE IN BODY FLUID - Provided are methods for determining the amount of total thiamine in a body fluid sample using liquid chromatography and mass spectrometry. Total thiamine is converted to free thiamine by treatment with an acid phosphatase prior to thiamine separation and quantification. | 04-09-2009 |
| 20100084545 | Methods for Detecting Vitamin C by Mass Spectrometry - Provided are methods for determining the amount of vitamin C in a sample using mass spectrometry. The methods generally involve ionizing vitamin C in a sample and detecting and quantifying the amount of the ion to determine the amount of vitamin C in the sample. | 04-08-2010 |
| 20100084546 | METHODS FOR DETECTING DIHYDROTESTOSTERONE BY MASS SPECTROMETRY - Provided are methods for determining the amount of dihydrotestosterone (DHT) in a sample using mass spectrometry. The methods generally involve ionizing DHT in a sample and detecting and quantifying the amount of the ion to determine the amount of DHT in the sample. | 04-08-2010 |
| 20110006197 | METHODS FOR DETECTING DIHYDROTESTOSTERONE BY MASS SPECTROMETRY - Provided are methods for determining the amount of dihydrotestosterone (DHT) in a sample using mass spectrometry. The methods generally involve ionizing DHT in a sample and detecting and quantifying the amount of the ion to determine the amount of DHT in the sample. | 01-13-2011 |
| 20110111512 | QUANTITATION OF INSULIN-LIKE GROWTH FACTOR-I AND INSULIN-LIKE GROWTH FACTOR-II WITH HIGH-RESOLUTION MASS SPECTROMETRY - Methods are provided for determining the amount of an IGF-I and/or IGF-II protein in a sample using high resolution/high accuracy mass spectrometry. The methods generally comprise enriching an IGF-I and/or IGF-II protein in a sample, ionizing an IGF-I and/or IGF-II protein from the sample to generate IGF-I and/or IGF-II protein ions, and determining the amount of IGF-I and/or IGF-II protein ions with high resolution/high accuracy mass spectrometry. | 05-12-2011 |
| 20110179855 | METHODS FOR DETECTING VITAMIN C BY MASS SPECTROMETRY - Provided are methods for determining the amount of vitamin C in a sample using mass spectrometry. The methods generally involve ionizing vitamin C in a sample and detecting and quantifying the amount of the ion to determine the amount of vitamin C in the sample. | 07-28-2011 |
| 20110297825 | MASS SPECTROMETRY METHOD FOR MEASURING VITAMIN B6 IN BODY FLUIDS - Provided are methods of detecting the presence or amount of the active form of vitamin B6, pyridoxal 5′-phosphate, in a body fluid sample using tandem mass spectrometry coupled with liquid chromatography. | 12-08-2011 |
Russell N. Reitz, Camarillo, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20090142277 | TREATMENT OF ACTIVE INFECTIONS AND RELATED COMPOSITIONS - The present invention is directed to the treatment of infections and the associated symptoms of sinusitis, rhinitis and related neurological disorders of the cranial cavity and facial tissue. More specifically, the present invention is directed to aerosols that are used to treat infections and the associated symptoms of sinusitis, rhinitis and related neurological disorders of the cranial cavity and facial tissue, compositions from which the aerosols are generated and methods of generating the aerosols. In an aerosol aspect of the present invention, an aerosol for delivery to the sinus cavity of a patient is provided. The aerosol includes at least: a) one or more compounds selected from antibiotics, antifungals, leukotriene antagonists, anti-TNF compounds, antihistamines, steroidal antiinflammatories, mucolytics, estrogen, progesterone and related hormones; and, b) water The compounds are present in the water at a concentration ranging from 0.01 mg/kg to 1000 mg/kg, and the aerosol does not contain a surfactant. | 06-04-2009 |
| 20110275587 | TOPICAL DELIVERY OF VISCOUS MEDICATIONS FOR THE TREATMENT OF DISEASES ASSOCIATED WITH CHRONIC SINUSITIS - A medication or combination of medications for the treatment of a disease involving the sinuses is incorporated into a sterile medical gel. The viscosity of the gel or the adhesion of the gel to the patient's sinus cavity allows the gel to be maintained in the cavity for a sufficient length of time for treatment of the affected area. This reduces the amount of wasted medication that would otherwise result from other topical methods. | 11-10-2011 |